These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34463375)

  • 21. Contradictory iPledge Requirements Hinder Physician Practice and Patient Care-Reply.
    Tkachenko E; Singer S; Mostaghimi A
    JAMA Dermatol; 2020 Feb; 156(2):222-223. PubMed ID: 31895435
    [No Abstract]   [Full Text] [Related]  

  • 22. Vitamin D levels in acne vulgaris patients treated with oral isotretinoin.
    El-Hamd MA; El Taieb MA; Ibrahim HM; Aly SS
    J Cosmet Dermatol; 2019 Feb; 18(1):16-20. PubMed ID: 29460332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral Vitamin A for Acne Management: A Possible Substitute for Isotretinoin.
    Cook M; Perche P; Feldman S
    J Drugs Dermatol; 2022 Jun; 21(6):683-686. PubMed ID: 35674761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isotretinoin (roaccutane) usage--a South African consensus guideline. National Dermatology Working Group.
    S Afr Med J; 1997 Oct; 87(10 Pt 2):1410-3. PubMed ID: 11496385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission.
    Borghi A; Mantovani L; Minghetti S; Giari S; Virgili A; Bettoli V
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1094-8. PubMed ID: 21198947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?
    Yıldızgören MT; Rifaioğlu EN; Demirkapı M; Ekiz T; Micooğulları A; Şen T; Turhanoğlu AD
    Cutis; 2015 Jul; 96(1):33-6. PubMed ID: 26244352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system.
    Shin J; Cheetham TC; Wong L; Niu F; Kass E; Yoshinaga MA; Sorel M; McCombs JS; Sidney S
    J Am Acad Dermatol; 2011 Dec; 65(6):1117-25. PubMed ID: 21565419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myths of isotretinoin therapy in patients with acne: a personal opinion.
    Alcalay J
    J Drugs Dermatol; 2004; 3(2):179-82. PubMed ID: 15098974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
    Gollnick HP; Graupe K; Zaumseil RP
    Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Call for Gender Identity Data Collection in iPLEDGE and Increasing the Number of Isotretinoin Prescribers Among Transgender Health Providers.
    Singer S; Keuroghlian AS
    LGBT Health; 2020 Jul; 7(5):216-219. PubMed ID: 32456537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of isotretinoin on obsessive compulsive symptoms, depression, and anxiety in patients with acne vulgaris.
    Yesilova Y; Bez Y; Ari M; Kaya MC; Alpak G
    J Dermatolog Treat; 2012 Aug; 23(4):268-71. PubMed ID: 21815780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safe and successful treatment of acne vulgaris with isotretinoin in a patient with chronic granulomatous disease.
    Alonso-de-Celada RM; de-Lucas Laguna R
    Pediatr Dermatol; 2012; 29(5):662-3. PubMed ID: 21966949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris.
    Öktem A; Hayran Y; Arı E; Yalçın B
    J Dermatolog Treat; 2019 Dec; 30(8):813-817. PubMed ID: 30836808
    [No Abstract]   [Full Text] [Related]  

  • 34. Challenges in optimizing isotretinoin use for acne vulgaris.
    McIntee TJ; Bruckner AL
    JAMA Dermatol; 2013 Dec; 149(12):1398. PubMed ID: 24172999
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.
    Zainab Z; Malik NA; Obaid S; Malik S; Aftab K; Mumtaz M; Pervez A; Syed Z
    J Ayub Med Coll Abbottabad; 2021; 33(1):60-63. PubMed ID: 33774956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
    Rademaker M
    Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guideline-based clinical decision support in acne patients receiving isotretinoin: improving adherence and cost-effectiveness.
    Borgonjen RJ; de Lange JA; van de Kerkhof PCM
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):e440-e442. PubMed ID: 28370604
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse effects of isotretinoin therapy for acne vulgaris.
    Lamb SR; Oakley AM
    N Z Med J; 2001 Sep; 114(1139):414. PubMed ID: 11665936
    [No Abstract]   [Full Text] [Related]  

  • 40. Re-evaluating the need for routine laboratory monitoring in patients taking isotretinoin: A retrospective analysis.
    Shah R; Kroshinsky D
    J Am Acad Dermatol; 2021 Aug; 85(2):504-506. PubMed ID: 30315820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.